Table 6.
Author(s), year | Study design | Sample size & Total leg ulcers | Clinical indicators used |
---|---|---|---|
Beele et al, 201080 Belgium and Netherlands |
A randomised, prospective, open label, multi‐centre, multi‐national trial Compared antimicrobial effects of an ionic silver alginate/carboxymethylcellulose dressing with a non‐silver calcium alginate fibre dressing |
36 clinically, critically colonised wounds: 24 CLUs | Continuous pain erythema, warmth, Moderate to serious exudates, >50% yellow/slough, discolouration of granulation tissue, friable granulation tissue that bleeds easily, pocketing at wound base, foul odour, and necrotic |
Braumann et a., 201164 Germany |
A cohort study |
52 wounds: 2 CLUs 12 infected wounds |
Pus, malodour, pain, erythema, oedema, and warmth |
Bruce et al, 201265 United Kingdom and Ireland |
A multi‐centre pre‐post evaluation study | 14 chronic wounds: 10 CLUs | Erythema, heat, oedema, pain, and odour |
Derbyshire, 201069 | Case studies | 3 cases: 2 CLUs | Delayed healing, heavy slough, extreme pain between dressing changes, heavy exudate; swelling |
Dryden et al, 201688 |
Non‐comparative pre‐post evaluation study in a multi‐centre, international setting To explore the clinical effects of Surgihoney RO, a topical wound dressing in bacterial load, biofilm and healing |
114 clinically infected wounds: 33 CLUs | Non‐healing, wound deterioration, green‐tinged or purulent/haemopurulent/seropurulent exudate, heavy or moderate level of exudate, slough or necrotic tissue. |
Forlee et al, 201453 South Africa |
A prospective, open, multi‐centre observational study To assess the clinical acceptability of the new gelling fibre dressing containing silver DURAFIBER Ag |
14 VLUs: 12 clinically infected | Wound static or deteriorating, increased exudate/secretion levels, increased pain, increased temperature around the wound, discolouration of granulation tissue, friable granulation, tissue necrosis, local erythema, oedema, purulent drainage, and odour |
Gago et al, 200854 Spain |
A prospective, comparative, observational study To compare 3 types of silver dressing: Acticoat Comfeel Ag, hydrocolloid/Biatain Ag polyurethane foam; and Aquacel Ag |
75 patients with infected chronic wounds: 50 leg ulcers | Pain, redness, heat, oedema, and/or purulent exudate |
Harding et al, 201637 United Kingdom |
A pre‐market non‐comparative controlled trial study To investigate the safety and performance of a next‐generation antimicrobial dressing AQUACEL Ag+ |
42 patients with clinically infected VLUs | Pain between two dressing changes, peri‐ulcer skin erythema/inflammation, oedema, malodour, and heavy exudate |
Jørgensen et al, 200511 15 centres in 7 countries |
A multi‐centre, open, block‐randomised and controlled trial study To compare the effect of a sustained silver‐release foam dressing Contreet Foam with a foam dressing Allevyn Hydrocellular without added silver in critically colonised VLUs with delayed healing |
129 patients with CLUS, critically colonised | Wound healing stalled or delayed compared with the normal expectation for the patient; increased exudate levels within the past 4 weeks; increased pain in the study ulcer area within the past 4 weeks; discolouration of granulation tissue; and foul odour “clinical infection including erysipelas and cellulitis of periulcer skin” |
Jorgensen et al, 200874 Denmark |
An open non‐comparative observational study to investigate the effect and safety of Biatain‐Ibu combined with an ionised silver‐releasing wound contact layer‐ Physiotulle Ag | 24 patients with locally infected VLUs | Painful; discolouration of the granulation tissue; exuding, Wound healing stalled or delayed compared with the normal expectation for the patient; and malodour |
Lazareth et al, 201212 France |
An open‐labelled, randomised, controlled trial for 4 weeks To assess the ability of a silver lipidocolloid contact layer in comparison with the same wound dressing not impregnated with silver salts to promote the healing process |
102 patients with “heavy bacterial colonisation” VLUs | Pain between 2 dressing changes, peri‐wound erythema, oedema, foul odour, and heavy exudate. Patients presented with at least 3/5 local signs of heavy bacterial colonisation |
Meaume et al, 200589 |
A randomised open‐label multi‐centre comparative two‐arm parallel‐group trial 13 centres recruited 99 patients with either VLUs or PUs to evaluate the clinical impact of using a silver‐releasing hydro‐alginate dressing |
99 critically colonised chronic wounds: 71 VLUs | Continuous (spontaneous) pain, erythema, oedema, increase local warmth, moderate to high levels of exudate, at least 50% of the wound covered with yellow slough, discoloured or friable granulation tissue, pocketing or undermining at the base of the wound, or foul odour |
Murphy, 201655 United Kingdom |
4 case studies To describe the effect of Zorflex |
4 VLUs |
Case 1: painful 7/10, green slough; Case 2 yellow slough ~50%, heavy exudate, the wound failed to progress Case 3 painful non‐healing ulcer, the wound bed was red & inflamed, ~60% slough, wound was static, heavy exudate, excoriation to peri‐wound, failed to respond to treatment Case 4 the wound deteriorated, very painful 7/10, high volumes of exudate caused peri‐wound maceration |
Trial et al, 201056 France |
Prospective, open‐label, controlled, and randomised trial To compare the efficacy and tolerability of a new ionic silver alginate matrix Askina Calgitrol Ag with that of a standard silver‐free alginate dressing Algosteril |
42 locally infected chronic wounds: 12 leg ulcers | Clinical infection score: (0–18): fever, local heat, peri‐lesional erythema; persistent pain between 2 dressing changes, oedema, malodour, pus, exudate production |
Vanscheidt et al, 200373 Germany |
A multi‐centre, non‐comparative, non‐randomised, pilot trial To evaluate primarily the safety and the initial performance of the ionic silver dressing Aquacel Ag |
15 patients with CLUs: 11 clinically infected | Cellulitis, pain, slough, discharge, erythema, and friable granulation tissue |
Vanscheidt et al, 201213 43 centres in the United Kingdom, Germany, France, Denmark and Poland |
International, multi‐centre, double‐blind and randomised controlled clinical trial To evaluate the cytotoxic effect of octenidine dihydrochloride/phenoxyethanol in comparison with Ringer solution |
126 patients with locally infected chronic VLU | Presence of at least 2/9: abscess, cellulites, discharge, discolouration, friable granulation tissue that bleeds easily, unexpected pain/tenderness or change in the nature of pain, pocketing at base of wound or wound breakdown, bridging of the epithelium or soft tissue and abnormal smell |
Walker et al, 201557 Canada, United Kingdom, Germany, Denmark, Croatia, Spain, Lithuania, Italy, Czech, Rep Sweden, Bulgaria, Portugal, Slovakia, Netherlands |
An international, multi‐centre, pragmatic, non‐randomised observational study To assess the effectiveness of AQUACEL Ag + dressing in facilitating healing in a variety of hard‐to‐heal wounds that may have been compromised by infection and/or biofilm |
113 patients: 59 CLUs | Purulent exudate, erythema, oedema, malodour, friable granulation tissue, and discoloured granulation tissue |
Woo et al, 201214 Canada |
A prospective, open‐label, 4‐week randomised controlled trial To evaluate the effectiveness of a topical silver dressing that consists of silver alginate powder (Arglaes Powder) compared with moisture balance with foam alone‐ Optifoam |
34 critically colonised chronic wounds: 13 CLUs |
A standardised upper—critical colonisation: unhealthy tissue, pain, poor healing, exudate, and reek Lower—deep infection: larger in size, osseous tissue, warmth, oedema, and redness |
Woo et al, 201258 Canada |
Case series: 9 patients To evaluate the application of transdermal continuous topical oxygen therapy to promote healing in chronic wounds |
9 patients with CLUs |
Upper: unhealthy tissue, pain, poor healing, exudate, and reek for superficial wound infection Lower: larger size, osseous tissue, warmth, oedema, and redness for deep wound infection |
Woo & Heil, 201741 Canada |
Prospective, non‐randomised observational study To evaluate the performance of an antibacterial foam dressing containing methylene blue and gentian violet (Hydrofera Blue Classic dressing) |
29 participants CLUs with localised infection |
Upper: unhealthy tissue, pain, poor healing, exudate, and reek Lower: larger in size & new areas of breakdown, osseous tissue, warmth, oedema, and redness |
CLUs, chronic leg ulcers; PUs, pressure ulcers; VLUs, venous leg ulcers.